Information Provided By: 
Fly News Breaks for July 17, 2019
PFE, EXAS
Jul 17, 2019 | 07:34 EDT
Canaccord analyst Mark Massaro raised his price target on Exact Sciences (EXAS) to $125 from $118 following meetings with management. The analyst said the meetings were upbeat as current momentum appears solid and poised to continue for the foreseeable future. Management conveyed the Pfizer (PFE) partnership has been a "home run" and Massaro expects the momentum to accelerate. Massaro reiterated his Buy rating on Exact Sciences shares.
News For EXAS;PFE From the Last 2 Days
There are no results for your query EXAS;PFE
